Early Therapy Improves Outcomes of Exacerbations of Chronic Obstructive Pulmonary Disease
Top Cited Papers
- 15 June 2004
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 169 (12) , 1298-1303
- https://doi.org/10.1164/rccm.200310-1443oc
Abstract
Treatment of chronic obstructive pulmonary disease (COPD) exacerbations improves outcomes; however, responses to treatment are variable, and patients with COPD often delay presentation or fail to seek therapy. The impact on exacerbation outcomes, hospitalization, and health status of delaying or failing to seek treatment is poorly understood. We studied between 1996 and 2002 a cohort of 128 patients with COPD, mean (SD) FEV(1) of 1.07 (0.43) L. Patients recorded respiratory symptoms daily and reported exacerbations to the outpatient-based study team or to their primary care physician; 1,099 exacerbations were recorded by the patients, of which 658 were reported to a physician. The time between exacerbation onset and treatment was a median (interquartile range) of 3.69 (2.0-5.57) days, and the exacerbation recovery time was 10.7 (7.0-14.0) days. Earlier treatment was associated with a faster recovery (regression coefficient 0.42 days/day delay) (confidence interval, 0.19-0.65; p < 0.001). Patients who reported a higher proportion of exacerbations for treatment had better health-related quality of life than those patients with more untreated exacerbations (rho = -0.22, p = 0.018). Failure to report exacerbations was associated with an increased risk of emergency hospitalization (rho = 0.21, p = 0.04). Patient recognition of exacerbation symptoms and prompt treatment improves exacerbation recovery, reduces risks of hospitalization, and is associated with a better health-related quality of life.Keywords
This publication has 30 references indexed in Scilit:
- Time course of recovery of health status following an infective exacerbation of chronic bronchitisThorax, 2003
- Outpatient Oral Prednisone after Emergency Treatment of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2003
- Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialThe Lancet, 2003
- Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax, 2002
- Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbationsThorax, 2002
- The Excess Cost of Acute Exacerbations of Chronic Bronchitis in Patients Aged 45 and Older in England and WalesValue in Health, 2001
- Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study)European Respiratory Journal, 2000
- Effect of Systemic Glucocorticoids on Exacerbations of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 1999
- The Annual Cost of Chronic Obstructive Pulmonary Disease to the UK??s National Health ServiceDisease Management and Health Outcomes, 1999
- Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia.Thorax, 1996